Product Information
BUPROPION HCL XL 150 MG TABLET is a generic product labeled by TWi Pharmaceuticals, Inc., priced at $0.0779 per EA under NDC 24979010106. Its NADAC has been published 406 times since Sep 26, 2018.
FDA first approved this application on Nov 3, 2017.
Strength
150 mg/1
Manufacturer
TWi Pharmaceuticals, Inc.NDC
24979010106
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
6/17/2026
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210081FDA Approved
11/3/2017
On Market Since
8/30/2018
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL XL 150 MG TABLET has been published 406 times since Sep 26, 2018, and over the history we have for it it has declined 74.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0779 per EA |
|---|---|
| All-time high | $0.3117 (Aug 14, 2019) |
| All-time low | $0.0745 (Nov 20, 2024) |
| 52-week high | $0.0996 |
| 52-week low | $0.0770 |
| Median price | $0.1202 |
| Average price | $0.1497 |
| Largest weekly change | -30.3% (Nov 20, 2024) |
| Weeks tracked | 406 |
| Tracking since | Sep 26, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
-1.7%
1Y
-21.8%
3Y
-23.2%
5Y
-51.0%
All
-74.4%
Last surveyed Jul 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
TWi Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
bupropion hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoketone class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUPROPION HCL XL 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL XL 150 MG TABLET, manufactured by TWi Pharmaceuticals, Inc., is $0.0779 per EA (NDC 24979010106), effective Jul 1, 2026.
How has the price of BUPROPION HCL XL 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL XL 150 MG TABLET has declined 74.4%. It has been tracked across 406 weekly CMS publications since Sep 26, 2018.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL XL 150 MG TABLET?
Since Sep 26, 2018, the NADAC for BUPROPION HCL XL 150 MG TABLET has ranged from a low of $0.0745 (Nov 20, 2024) to a high of $0.3117 (Aug 14, 2019), with a median of $0.1202 per EA.
Are there cheaper alternatives to BUPROPION HCL XL 150 MG TABLET?
14 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPROPION HCL XL 150 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BUPROPION HCL XL 150 MG TABLET?
BUPROPION HCL XL 150 MG TABLET (NDC 24979010106) is labeled by TWi Pharmaceuticals, Inc., and CMS classifies it as a generic product.